Repertoire Immune Medicines
Developing T cell-targeted therapies for cancer and autoimmune diseases.
SoftBank Vision Fund — Backed by SoftBank Vision Fund H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.biotech
Company facts
- Founded
- 2019
- Employees
- 90
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $189M · 2021
Open positions
1 job